https://www.selleckchem.com/pr....oducts/pf-06650833.h
Additionally, serum exosomal miR-151a-3p showed a reduction of 28.1% (P=.031). We confirmed the clinical efficacy of low-dose rituximab in MuSK-MG, accompanied by a decrease in MuSK antibody titers and an increase in serum BAFF. Serum BAFF levels negatively correlated with B-cell counts as well as clinical severity. We confirmed the clinical efficacy of low-dose rituximab in MuSK-MG, accompanied by a decrease in MuSK antibody titers and an increase in serum BAFF. Serum BAFF levels negatively correlated with B-cell counts as well as
Like
Comment
Share
